Paramount Bed Holdings Future Growth
Future criteria checks 3/6
Paramount Bed Holdings is forecast to grow earnings and revenue by 15.4% and 6.7% per annum respectively. EPS is expected to grow by 17.8% per annum. Return on equity is forecast to be 8.1% in 3 years.
Key information
15.4%
Earnings growth rate
17.8%
EPS growth rate
Medical Equipment earnings growth | 12.6% |
Revenue growth rate | 6.7% |
Future return on equity | 8.1% |
Analyst coverage | Low |
Last updated | 31 Oct 2024 |
Recent future growth updates
Recent updates
Paramount Bed Holdings (TSE:7817) Hasn't Managed To Accelerate Its Returns
Oct 31Paramount Bed Holdings' (TSE:7817) Upcoming Dividend Will Be Larger Than Last Year's
Sep 04Paramount Bed Holdings (TSE:7817) Will Pay A Larger Dividend Than Last Year At ¥48.00
Aug 21Paramount Bed Holdings (TSE:7817) Is Increasing Its Dividend To ¥48.00
Jul 26Paramount Bed Holdings' (TSE:7817) Dividend Will Be Increased To ¥48.00
Jul 11Paramount Bed Holdings (TSE:7817) Will Pay A Larger Dividend Than Last Year At ¥34.00
Mar 03Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 124,550 | 11,700 | 10,557 | N/A | 2 |
3/31/2026 | 117,850 | 10,700 | 9,732 | N/A | 2 |
3/31/2025 | 111,500 | 9,500 | 9,900 | N/A | 1 |
9/30/2024 | 104,970 | 7,596 | N/A | N/A | N/A |
6/30/2024 | 104,843 | 9,329 | N/A | N/A | N/A |
3/31/2024 | 106,016 | 10,622 | 3,286 | 7,521 | N/A |
12/31/2023 | 100,956 | 9,141 | N/A | N/A | N/A |
9/30/2023 | 101,879 | 9,469 | 2,492 | 6,876 | N/A |
6/30/2023 | 100,575 | 9,389 | N/A | N/A | N/A |
3/31/2023 | 99,009 | 9,215 | 5,349 | 9,151 | N/A |
12/31/2022 | 97,499 | 8,254 | N/A | N/A | N/A |
9/30/2022 | 95,965 | 9,211 | 7,150 | 9,296 | N/A |
6/30/2022 | 92,684 | 9,428 | N/A | N/A | N/A |
3/31/2022 | 90,352 | 9,092 | 6,301 | 7,822 | N/A |
12/31/2021 | 90,767 | 10,858 | N/A | N/A | N/A |
9/30/2021 | 90,360 | 10,911 | 8,354 | 10,737 | N/A |
6/30/2021 | 90,550 | 9,906 | N/A | N/A | N/A |
3/31/2021 | 87,171 | 8,611 | 6,557 | 10,279 | N/A |
12/31/2020 | 84,681 | 7,191 | N/A | N/A | N/A |
9/30/2020 | 81,475 | 6,218 | 5,233 | 8,983 | N/A |
6/30/2020 | 82,281 | 6,850 | N/A | N/A | N/A |
3/31/2020 | 82,379 | 7,043 | 5,971 | 9,087 | N/A |
12/31/2019 | 82,777 | 6,640 | N/A | N/A | N/A |
9/30/2019 | 82,281 | 6,461 | 4,344 | 6,451 | N/A |
6/30/2019 | 79,641 | 6,435 | N/A | N/A | N/A |
3/31/2019 | 80,088 | 6,704 | 5,952 | 7,914 | N/A |
12/31/2018 | 79,851 | 7,732 | N/A | N/A | N/A |
9/30/2018 | 79,184 | 8,084 | 6,323 | 9,325 | N/A |
6/30/2018 | 78,789 | 8,212 | N/A | N/A | N/A |
3/31/2018 | 77,220 | 8,366 | N/A | 9,967 | N/A |
12/31/2017 | 77,208 | 9,557 | N/A | N/A | N/A |
9/30/2017 | 75,610 | 10,325 | N/A | 10,754 | N/A |
6/30/2017 | 73,722 | 10,004 | N/A | N/A | N/A |
3/31/2017 | 73,198 | 9,034 | N/A | 12,019 | N/A |
12/31/2016 | 72,799 | 7,404 | N/A | N/A | N/A |
9/30/2016 | 73,070 | 6,368 | N/A | 10,717 | N/A |
6/30/2016 | 73,983 | 5,785 | N/A | N/A | N/A |
3/31/2016 | 74,089 | 6,387 | N/A | 9,657 | N/A |
12/31/2015 | 74,609 | 6,737 | N/A | N/A | N/A |
9/30/2015 | 74,803 | 6,666 | N/A | 8,457 | N/A |
6/30/2015 | 74,695 | 7,028 | N/A | N/A | N/A |
3/31/2015 | 75,270 | 7,264 | N/A | 8,151 | N/A |
12/31/2014 | 77,544 | 8,174 | N/A | N/A | N/A |
9/30/2014 | 75,914 | 7,859 | N/A | 7,026 | N/A |
6/30/2014 | 74,101 | 7,554 | N/A | N/A | N/A |
3/31/2014 | 72,794 | 7,384 | N/A | 6,373 | N/A |
12/31/2013 | 67,179 | 6,497 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 7817's forecast earnings growth (15.4% per year) is above the savings rate (0.3%).
Earnings vs Market: 7817's earnings (15.4% per year) are forecast to grow faster than the JP market (7.7% per year).
High Growth Earnings: 7817's earnings are forecast to grow, but not significantly.
Revenue vs Market: 7817's revenue (6.7% per year) is forecast to grow faster than the JP market (4.1% per year).
High Growth Revenue: 7817's revenue (6.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 7817's Return on Equity is forecast to be low in 3 years time (8.1%).